Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Hypertension League Institute is a specialized research organization based in China, dedicated to the study, prevention, and management of hypertension and cardiovascular diseases. Established in affiliation with the Chinese Hypertension League, the institute plays a pivotal role in conducting large-scale clinical trials and epidemiological research that shape national health policies. It provides a range of services including clinical trial management, professional medical training, and the development of clinical practice guidelines. The institute is well-regarded for its international collaborations and its contribution to significant cardiovascular outcome trials such as the FEVER and CHIEF studies. Through its work, the institute aims to reduce the burden of hypertension-related complications like stroke and heart failure across the Chinese population.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Hypertension League Institute.